How much funding has Ionis Pharmaceuticals raised?

Ionis Pharmaceuticals has raised $235.2M in total funding, most recently a Corporate Round.

Who are Ionis Pharmaceuticals's investors?

Ionis Pharmaceuticals's investors include AstraZeneca, Ciba-Geigy, Bessemer VP.

When was Ionis Pharmaceuticals founded?

Ionis Pharmaceuticals was founded in 1989.

Where is Ionis Pharmaceuticals headquartered?

Ionis Pharmaceuticals is headquartered in Carlsbad, California, United States.

What industry is Ionis Pharmaceuticals in?

Ionis Pharmaceuticals operates in Biotech, Healthcare.

How many employees does Ionis Pharmaceuticals have?

Ionis Pharmaceuticals has 1001-5000 employees.

Ionis Pharmaceuticals

IPO

Pioneering the Future of Medicine

Public · Carlsbad, United States · Founded 1989 · $235.2M raised

Biotech

Healthcare

Headquarters: Carlsbad, California
Employees: 1001–5000
Founded: 1989
Business Model: B2B
Website: ionis.com

Total Funding: $235.2M
Last Round: $200.0M Corporate RoundApr 2021
Rounds: 3
Type: Public

About

Ionis Pharmaceuticals is a pioneer in RNA-targeted medicine, founded in 1989 in Carlsbad, California. Over more than three decades, the company has discovered and developed six marketed medicines for serious diseases including neurological and cardiovascular conditions, with breakthrough approvals including SPINRAZA for spinal muscular atrophy and QALSODY for ALS. In 2020, Ionis transitioned to a fully integrated biotech, independently commercializing its wholly owned late-stage pipeline.

Summary

Ionis Pharmaceuticals is a Biotech company based in Carlsbad, United States, founded in 1989. It has raised $235.2M in total across 3 rounds, most recently a $200.0M Corporate Round round in Apr 2021. Investors include AstraZeneca, Ciba-Geigy and Bessemer VP.

LinkedIn X (Twitter)